| 注册
首页|期刊导航|河南中医|中医药治疗膜性肾病大鼠蛋白尿研究进展

中医药治疗膜性肾病大鼠蛋白尿研究进展

张寒 赵幸如 吴宇清 高坤

河南中医2024,Vol.44Issue(5):804-810,7.
河南中医2024,Vol.44Issue(5):804-810,7.DOI:10.16367/j.issn.1003-5028.2024.05.0148

中医药治疗膜性肾病大鼠蛋白尿研究进展

Research Progress of TCM in the Treatment of Proteinuria in Rats with Membranous Nephropathy

张寒 1赵幸如 1吴宇清 1高坤1

作者信息

  • 1. 南京中医药大学附属医院,江苏 南京 210029
  • 折叠

摘要

Abstract

TCM treatments of membranous nephropathy(MN)rats with proteinuria include tonifying kidney and activating blood circu-lation,banking up and strengthening absorption,tonifying kidney and removing wind,nourishing qi and activating blood circulation to e-liminate dampness,cooling blood to expel turbidity and detoxification,etc.The representative formulas include Spleen-Invigorating and Kidney-Replenishing and Blood-Activating Formula,Shendi Granules,Formula for Reinforcing the Healthy Qi and Eliminating Wind,Astragalus and Os Draconis Formula for Dredging the Kidney,Compound Snake-Dragon Capsules,etc.The active ingredients of Chinese drugs also have the effect of improving proteinuria in MN rats,including alkaloids,polyphenols,terpenes,flavonoids,etc.compound for-mulas of Chinese drugs and active ingredients can play a role in the treatment of MN through anti-inflammatory,anti-oxidative stress,an-ti-apoptosis,reducing the deposition of immune complexes and inhibiting glomerular podocyte mesenchymal transformation.The current research has the following deficiencies:(1)The research of Chinese drugs'active ingredients is mostly in the experimental stage,lacking sufficient clinical evidence;(2)The research of compound formulas of Chinese drugs for the treatment of MN lacks unified syndrome differentiation and efficacy judgment standards;(3)The mechanism of TCM in the treatment of MN proteinuria is still unclear.In the fu-ture,clinical trials should be strengthened to promote the transformation of achievements,and high-quality,multi-center,large-sample clinical research should be carried out to further study its target and signal pathway.

关键词

膜性肾病/中药复方/活性成分/蛋白尿

Key words

membranous nephropathy(MN)/compound formulas of Chinese drugs/active ingredient/proteinuria

分类

医药卫生

引用本文复制引用

张寒,赵幸如,吴宇清,高坤..中医药治疗膜性肾病大鼠蛋白尿研究进展[J].河南中医,2024,44(5):804-810,7.

基金项目

青年岐黄学者培养项目{国中医药人教发[2020]7号} ()

江苏省中医药领军人才项目{苏中医科教[2023]17号} ()

河南中医

1003-5028

访问量0
|
下载量0
段落导航相关论文